Meyns Joeri, Thanatchaporn Jindanil, Shujaat Sohaib, Politis Constantinus, Jacobs Reinhilde
Ziekenhuis Oost-Limburg, Genk, Belgium.
KU Leuven, Leuven, Belgium.
Prog Orthod. 2025 Apr 21;26(1):14. doi: 10.1186/s40510-025-00561-7.
Early intervention in Class III malocclusion aims to prevent the need for surgery in adulthood by enhancing upper jaw growth while limiting lower jaw development. Although traditional facemask treatment remain common, bone-anchored devices are increasingly used, claiming better skeletal control and patient compliance. However, strong evidence supporting these advantages is limited.
Single-center, parallel-group, randomized controlled trial with 1:1 allocation ratio.
28 growing Class III patients (mean age 9.7 ± 1.3 years) in mixed dentition with skeletal class III malocclusion.
Patients were randomly assigned to either hybrid hyrax with facemask (HH + FM, n = 14) or hybrid hyrax with mentoplate (HH + MP, n = 14). All received Alt-RAMEC protocol expansion. FM group used 360-400 g/side elastic traction 12-14 h daily; MP group used 185 g/side continuous traction.
To compare 5-year three-dimensional (3D) skeletal effects between HH + FM and HH + MP protocols.
Primary outcome was 3D volumetric changes of upper and lower jaw at 1 year (T1) and 5 years (T2) post-treatment, measured using low-dose CT scans.
28 patients were allocated to either treatment-protocols using sequentially numbered opaque, sealed envelopes. The randomization sequence was generated with a 1:1 allocation ratio.
Due to the nature of the trial, the operator and children could not be blinded to the treatment allocation. However, blinding was used when assessing the outcomes.
Follow-up: one patient was lost at the one-year follow-up and an additional three patients were lost at the 5-year-follow-up.
At T2 (5 years), maxillary advancement was identical between both groups (0.85 mm ± 0.5). Mandibular growth control showed minimal difference (FM: - 0.01 mm ± 0.24; MP: 0.10 mm ± 0.33). No significant differences were found between groups for any skeletal measurements (p > 0.05). Male patients showed lager mandibular changes both signed (p < 0.03) and unsigned (p < 0.01).
minor harms were encountered with the anchor hooks (fracture or mucosal irritation), however none led to treatment cessation.
Both protocols demonstrated comparable long-term skeletal effects in Class III correction. Treatment choice should be based on individual patient factors rather than assumed mechanical advantages.
对III类错牙合畸形进行早期干预旨在通过促进上颌生长同时限制下颌发育,以避免成年后进行手术。尽管传统的面罩治疗仍然很常见,但骨锚式装置的使用越来越多,据称其能更好地控制骨骼并提高患者依从性。然而,支持这些优势的有力证据有限。
单中心、平行组、随机对照试验,分配比例为1:1。
28例处于混合牙列期的生长发育期III类患者(平均年龄9.7±1.3岁),患有骨骼III类错牙合畸形。
患者被随机分为混合扩弓器联合面罩组(HH + FM,n = 14)或混合扩弓器联合颏兜组(HH + MP,n = 14)。所有患者均接受Alt-RAMEC方案扩弓。FM组每天使用360 - 400 g/侧弹性牵引12 - 14小时;MP组使用185 g/侧持续牵引。
比较HH + FM和HH + MP方案在5年时的三维(3D)骨骼效应。
主要结果是治疗后1年(T1)和5年(T2)时上下颌的3D体积变化,采用低剂量CT扫描测量。
28例患者使用顺序编号的不透明密封信封分配至两种治疗方案之一。随机分组序列按1:1分配比例生成。
由于试验性质所致,操作者和儿童无法对治疗分配情况设盲。然而,在评估结果时采用了盲法。
随访:1例患者在1年随访时失访,另外3例患者在5年随访时失访。
在T2(5年)时,两组上颌前移情况相同(0.85 mm±0.5)。下颌生长控制差异极小(FM组:-0.01 mm±0.24;MP组:0.1 mm±0.33)。两组间任何骨骼测量指标均未发现显著差异(p>0.05)。男性患者下颌变化无论是有符号(p<0.03)还是无符号(p<0.01)均更大。
锚钩出现了轻微不良事件(骨折或黏膜刺激),但均未导致治疗中断。
两种方案在III类错牙合畸形矫治中均显示出相当的长期骨骼效应。治疗选择应基于个体患者因素,而非假定的机械优势。